Health
Full intensity heparin has value in treating hospitalized COVID-19 patients – News-Medical.Net
Results from the RAPID clinical trial suggest heparin may lower the risk of death from moderate COVID-19 infection by 78%. Heparin…
Heparin is typically administered for blood clotting, but its anti-inflammatory and anti-viral effects have captured interest as a potential COVID-19 treatment. An international team of researchers led by Peter Jüni of St. Michael’s Hospital and the University…
Continue Reading
-
Noosa News12 hours agoPrincess Anne visits Gallipoli Barracks in Brisbane on Remembrance Day as Australian tour ends
-
Business23 hours agoWhere to invest $5,000 in ASX ETFs in November
-
Noosa News10 hours agoRoyal visit to Gallipoli Barracks in Enoggera on Remembrance Day
-
General13 hours ago‘Do you care?’: Coles stares down anti-salmon activists